Saturday, October 24, 2026 The gateway for independent voices — journalism, podcasts & documentaries
RSS
Established for Independent Voices
IJNN.World
Independent Journalist News Network


Breaking
— Best high-yield savings interest rates today, Friday, October 23, 2026: Earn up to 4.3% APY — How Elon Musk went from Tesla CEO to the ‘most powerful civilian, non-governmental actor in history’ — Wall Street’s safest stock is having its biggest day since the pandemic crash — here’s why investors are paying up — Political Skirmishes in “Other Desert Cities” and “A Bright Room Called Day” — Best high-yield savings interest rates today, Friday, October 23, 2026: Earn up to 4.3% APY — How Elon Musk went from Tesla CEO to the ‘most powerful civilian, non-governmental actor in history’ — Wall Street’s safest stock is having its biggest day since the pandemic crash — here’s why investors are paying up — Political Skirmishes in “Other Desert Cities” and “A Bright Room Called Day”

Uncategorized

OncoSil Medical Plans ASX Share Placement to Raise Capital

OncoSil Medical Ltd ( (AU:OSL) ) has issued an update. OncoSil Medical Ltd has announced a proposed placement of up to 4,000,000 ordinary fully paid shares on the ASX. The new securities are scheduled for issue on 10 September 2026, subject to ASX processes and quotation. The capital raising via this share placement is intended […]

OncoSil Medical Ltd ( (AU:OSL) ) has issued an update.

OncoSil Medical Ltd has announced a proposed placement of up to 4,000,000 ordinary fully paid shares on the ASX. The new securities are scheduled for issue on 10 September 2026, subject to ASX processes and quotation.

The capital raising via this share placement is intended to support OncoSil Medical’s ongoing operations and growth initiatives. The move may lead to share dilution for existing shareholders but provides the company with additional funding flexibility in a competitive medical technology market.

More about OncoSil Medical Ltd OncoSil Medical Ltd is a listed medical technology company focused on developing and commercialising oncology treatments. The company’s shares trade on the ASX under the ticker OSL, giving it access to public capital markets to fund its clinical and commercial activities in cancer care.

This story was written using TipRanks’s AI tools and reviewed by a TipRanks editor.…Read more by TipRanks Australian Auto-Generated Newsdesk

‹ Boy with rare genetic condition meets… Scholarship Honors Middlesex County Man -… ›